Skip to main content

Table 4 Ordinal regression models for high HFA-PEFF scores in myositis patients

From: Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population

 

Univariate

 

Multivariate

 

Covariates

OR (95% CI)

p—value

OR (95% CI)

p—value

Age

1.03 (1.01–1.05)

0.001

  

Body mass index

1.07(1.00–1.15)

0.045

  

Hypertension

2.91(1.63–5.20)

 < 0.001

  

Diabetes mellitus

2.44(1.35–4.41)

0.003

  

Interstitial lung disease

1.81(1.05–3.11)

0.033

  

Dyspnea symptom

1.87(1.64–2.99)

0.010

1.52(0.83–2.76)

0.175

Palpitation symptom

3.24(1.86–5.64)

 < 0.001

2.59(1.35–4.99)

0.004

Anti-SRP antibody

2.53(1.04–6.16)

0.041

1.89(0.82–4.36)

0.133

Anti-TIF1γ antibody

1.69(0.53–5.36)

0.374

  

Anti-HMGCR antibody

0.55(0.15–2.04)

0.371

  

Anti-synthetase antibody

0.94(0.59–1.51)

0.806

  

Anti-Mi2 antibody

0.73(0.18–3.01)

0.659

  

Anti-MDA5 antibody

1.18(0.69–1.99)

0.549

  

AMA-M2

4.13(1.72–9.92)

0.001

3.80(1.49–9.68)

0.005

Elevated CK level

0.98(0.58–1.64)

0.923

  

Elevated LDH level

2.39(1.33–4.27)

0.003

3.59(1.86–6.92)

 < 0.001

Elevated cTnI level

4.31(2.14–8.67)

 < 0.001

4.43(2.03–9.65)

 < 0.001

  1. CK Creatine kinase, LDH Lactate dehydrogenase, cTnI Cardiac troponin I, OR Odd ratio, CI Confidence interval